Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Vancomycin in MRSA Pneumonia
NCT01925066Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2013
- Primary completion
- Dec 2017
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin in Staphylococcus aureus pneumonia, sponsored by Seoul National University Hospital. Started Aug 2013; status: completed.
02
Drugs
vancomycin
03
Conditions
Staphylococcus aureus pneumonia
Beyond the preview
Go deeper on NCT01925066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925066.